⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MPLT News
MapLight Therapeutics, Inc. Common Stock
MPLT Investors Have Opportunity to Join MapLight Therapeutics, Inc. Fraud Investigation with SBS Law
prnewswire.com
MPLT
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against MapLight Therapeutics, Inc. (MPLT) and Encourages Investors to Learn More About the Investigation
accessnewswire.com
MPLT
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against MapLight Therapeutics, Inc. (MPLT) and Encourages Stockholders to Learn More About the Investigation
accessnewswire.com
MPLT
Bronstein, Gewirtz & Grossman, LLC Encourages MapLight Therapeutics, Inc. (MPLT) Investors to Inquire about Securities Investigation
accessnewswire.com
MPLT
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against MapLight Therapeutics, Inc. (MPLT) And Encourages Investors to Reach Out
accessnewswire.com
MPLT
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against MapLight Therapeutics, Inc. (MPLT) And Encourages Stockholders to Reach Out
accessnewswire.com
MPLT
MPLT Investors Have Opportunity to Join MapLight Therapeutics, Inc. Fraud Investigation with SBS Law
businesswire.com
MPLT
Form 8-K
sec.gov
MPLT
MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia
globenewswire.com
MPLT
Form 8-K
sec.gov
MPLT